Company Overview of Bicycle Therapeutics Limited
Bicycle Therapeutics Limited, a biotherapeutics company, focuses on developing high constrained bicyclic peptides (bicycles) as novel class of therapeutics. The company is involved in developing a pipeline of bicycle molecules by using its proprietary bicyclic peptide technology that provides antibody-like affinity and selectivity in a much smaller chemically synthesized molecule. It applies its technology to various drug discovery projects, including oncology, ophthalmology, and other therapeutic areas through collaborative discovery partnerships with pharmaceutical companies. Bicycle Therapeutics Limited was founded in 2009 and is based in Cambridge, United Kingdom with an additional offic...
Babraham Research Campus
Cambridge, CB22 3AT
Founded in 2009
Key Executives for Bicycle Therapeutics Limited
President and Chief Business Officer
Co-Founder, Director and Member of Scientific Advisory Board
Compensation as of Fiscal Year 2016.
Bicycle Therapeutics Limited Key Developments
Bicycle Therapeutics Appoints Stephen J. Hoffman as Board Chairman
Jul 18 16
Bicycle Therapeutics announced the appointment of Stephen J. Hoffman, M.D., Ph.D., as chairman of the board of directors. Dr. Hoffman is President of 10x Capital Inc. and Senior Advisor to PDL BioPharma Inc. He also serves on the Board of Directors of Dicerna Pharmaceuticals Inc., AcelRx Pharmaceuticals Inc. and Genocea Biosciences Inc. Previously, he served as Managing Director at Skyline Ventures and as General Partner at TVM Capital.
Bicycle Therapeutics Limited Presents at 2016 BIO International Convention, Jun-08-2016 01:30 PM
Jun 3 16
Bicycle Therapeutics Limited Presents at 2016 BIO International Convention, Jun-08-2016 01:30 PM. Venue: Moscone Center, San Francisco, California, United States. Speakers: Rosamond Deegan, President and Chief Business Officer.
Bicycle Therapeutics Establishes U.S. Operations with Headquarters in Cambridge, Massachusetts; Appoints Rosamond Deegan as President and Chief Business Officer
May 23 16
Bicycle Therapeutics announced it has established U.S. operations with headquarters in Cambridge, Massachusetts and named Rosamond Deegan, as President and Chief Business Officer. In this newly created role, Ms. Deegan will be responsible for leading Bicycle Therapeutics' business development activities and establishing a U.S. team aligned with the company's focus on oncology clinical development. Deegan joined Bicycle Therapeutics from Trevena Inc. where she most recently served on the senior leadership team as Senior Vice President, Business Development and Operations and previously held the role of Head of Finance and Operations. Prior to joining Trevena, Ms. Deegan was Director of Business Development at GSK in the U.S. and, prior to that, she served as Director of Operations for GSK's Centre of Excellence for External Drug Discovery (CEED) and as Marketing Manager for GSK's U.K. launch of Bonviva for post-menopausal osteoporosis.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|